Approvals/TGA/DESCOVY 200 mg/25 mg (200 mg emtricitabine/25 mg tenofovir alafenamide) tablet bottle

Approved

STANDARD

DESCOVY 200 mg/25 mg (200 mg emtricitabine/25 mg tenofovir alafenamide) tablet bottle

Gilead Sciences Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c4e2947736cdc5cc
Product Name: DESCOVY 200 mg/25 mg (200 mg emtricitabine/25 mg tenofovir alafenamide) tablet bottle
Artg Id: 246092
Artg Name: DESCOVY 200 mg/25 mg ( 200 mg emtricitabine/25 mg tenofovir alafenamide) tablet bottle
Sponsor: Gilead Sciences Pty Ltd
Company Detail Path: /organization/gilead-sciences-pty-limited
Artg Date: 2016-07-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-02121-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-02118-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

c4e2947736cdc5cc

Type

Standard